Want to join the conversation?
Generic drug company $LCI reported a drop in 4Q16 earnings due to the inclusion of KU's lower-margin business, as well as amortization of acquired intangible assets and other purchase accounting related expenses. Net income fell to $3.57MM or $0.10 per share from $33.94MM or $0.91 per share last year. Non-GAAP EPS declined to $0.73 from $0.94.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th